Eaubonne, France

Michel Tellier

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignee: Laboratoire Francais Du Fractionnement Et Des Biotechnologies. Active years: 2016-2026.

USPTO Granted Patents = 3 

% Patents Active = 66.7

 

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016-2026

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Michel Tellier: Innovator in Protein Separation Technologies

Introduction

Michel Tellier is a notable inventor based in Eaubonne, France. He has made significant contributions to the field of biotechnology, particularly in the area of protein separation. With a total of 3 patents to his name, Tellier's work has the potential to impact various medical and scientific applications.

Latest Patents

Michel Tellier's latest patents focus on a groundbreaking process for separating proteins such as fibrinogen, factor XIII, and biological glue from a solubilized plasma fraction. This innovative method also includes the preparation of lyophilized concentrates of these proteins. His work in this area demonstrates a commitment to advancing biotechnological processes that can enhance medical treatments and research.

Career Highlights

Tellier is associated with Laboratoire Français Du Fractionnement Et Des Biotechnologies, where he applies his expertise in protein separation technologies. His career reflects a dedication to improving biotechnological methods and contributing to the scientific community.

Collaborations

Throughout his career, Michel Tellier has collaborated with esteemed colleagues such as Michel Nogre and Pierre Porte. These partnerships have likely enriched his research and development efforts, fostering innovation in the field.

Conclusion

In summary, Michel Tellier is a prominent inventor whose work in protein separation technologies is paving the way for advancements in biotechnology. His contributions are essential for the ongoing development of medical and scientific applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…